We updated the design of this site on December 18, 2017. Learn more.
ClinicalTrials.gov
ClinicalTrials.gov Menu
IMPORTANT: Due to the lapse in government funding, the information on this web site may not be up to date, transactions submitted via the web site may not be processed, and the agency may not be able to respond to inquiries until appropriations are enacted. Updates regarding government operating status and resumption of normal operations can be found at opm.gov.
Trial record 2 of 2318 for:    melanoma

Prospective Melanoma Database

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT02884362
Recruitment Status : Recruiting
First Posted : August 31, 2016
Last Update Posted : August 31, 2016
Sponsor:
Information provided by (Responsible Party):

Study Description
Brief Summary:

In research on melanoma, translational research is the essential link between basic research and clinical research by facilitating the passage between discovery and improvement in the quality of patients care.That is the reason why it is very important to collect, and centralize clinical and biological data of patients with melanoma.

The aim of the project is to provide to scientific community a structured, mixed clinical and biological database, unique in France, in order to insure accessibility to clinical data.


Condition or disease Intervention/treatment
Melanoma Other: clinical biological data collection on melanoma

Detailed Description:
collection of clinical and biological data from patients with melanomas of any stage in a structured and centralized database

Study Design

Study Type : Observational
Estimated Enrollment : 10000 participants
Time Perspective: Prospective
Official Title: Creation of a Prospective Melanoma Database
Study Start Date : January 2016
Estimated Primary Completion Date : January 2026
Estimated Study Completion Date : June 2026

Resource links provided by the National Library of Medicine

MedlinePlus related topics: Melanoma
U.S. FDA Resources

Groups and Cohorts

Intervention Details:
    Other: clinical biological data collection on melanoma
    collection and centralization of clinical and biological data of patients with melanoma

Outcome Measures

Primary Outcome Measures :
  1. Database of patients with melanoma [ Time Frame: 10 years ]

Biospecimen Retention:   Samples With DNA
tumor sample

Eligibility Criteria

Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Ages Eligible for Study:   18 Years and older   (Adult, Senior)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No
Sampling Method:   Non-Probability Sample
Study Population
Patients with any histological type of melanoma and of any stage
Criteria

Inclusion Criteria:

  • Age > 18 years
  • Histologically confirmed melanoma of any stage
  • Affiliated to a social security system in france
  • Who signed the informed consent

Exclusion Criteria:

  • Any psychiatric or medical condition that would make the patient unable to give a signed informed consent
Contacts and Locations

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT02884362


Contacts
Contact: Nicolas MEYER, MD PHD 5 31 15 51 61 ext 33 Meyer.Nicolas@iuct-oncopole.fr

Locations
France
Institut claudius regaud IUCT ONCOPOLE Recruiting
Toulouse, France, 31059
Contact: Nicolas MEYER, MD PHD    5 31 15 51 61 ext 33    Meyer.Nicolas@iuct-oncopole.fr   
Sponsors and Collaborators
Institut Claudius Regaud
Investigators
Principal Investigator: Nicolas MEYER, MD PHD Institut claudius regaud Toulouse ONCOPOLE
More Information

Responsible Party: Institut Claudius Regaud
ClinicalTrials.gov Identifier: NCT02884362     History of Changes
Other Study ID Numbers: 16HLCUTA01
First Posted: August 31, 2016    Key Record Dates
Last Update Posted: August 31, 2016
Last Verified: July 2016
Individual Participant Data (IPD) Sharing Statement:
Plan to Share IPD: Undecided

Keywords provided by Institut Claudius Regaud:
melanoma clinical biological database

Additional relevant MeSH terms:
Melanoma
Neuroendocrine Tumors
Neuroectodermal Tumors
Neoplasms, Germ Cell and Embryonal
Neoplasms by Histologic Type
Neoplasms
Neoplasms, Nerve Tissue
Nevi and Melanomas